Zevenbergen Capital Investments LLC Sage Therapeutics, Inc. Transaction History

Zevenbergen Capital Investments LLC

  • $4.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020
SELL
$26.15 - $77.24 $6.19 Million - $18.3 Million
-236,587 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$60.18 - $154.77 $8.62 Million - $22.2 Million
143,306 Added 153.63%
236,587 $17.1 Million
Q3 2019

Nov 08, 2019
BUY
$140.29 - $189.96 $13.1 Million - $17.7 Million
93,281 New
93,281 $13.1 Million

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Zevenbergen Capital Investments LLC Portfolio

Follow Zevenbergen Capital Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email